Lygos CBx scales up bio-based production of cannabinoids
A San Francisco Bay Area company that specializes in low-cost alternatives to plant-derived cannabinoids has launched commercial-scale production.…
News April 5A San Francisco Bay Area company that specializes in low-cost alternatives to plant-derived cannabinoids has launched commercial-scale production.…
News April 5The largest-yet human CBD toxicological trial has been launched in Europe to check the effects of consuming trace…
News March 19A rare cannabinoid that mimics the effects of delta-9 THC but can easily be produced from CBD is…
News March 16On December 17, the Federal Trade Commission (FTC) announced its first crackdown on deceptive marketing claims for CBD…
News January 18Canadian cannabis producer Canopy Growth Corp. is suing Britain's GW Pharmaceuticals in U.S. federal court, alleging that GW…
News December 23Low-THC cannabis producers can keep Europe on their radar as an export market in 2021 after the European…
News December 2One of the most hackneyed cliches about cannabis use – “stoner” memory failure – might be about to…
News September 10The first randomized clinical trial investigating the use of cannabidiol (CBD) to treat cannabis use disorder (CUD) has…
News August 26It wasn’t long ago that cannabis experts thought it unlikely anyone could produce cannabinoids in quantity through biosynthesis,…
News August 26